1-2 of 2
Ian Prosser, MBBS, FRACP, FRCPA, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Tolerability of Combination Therapy with Thalidomide and 5-Azacitidine in Patients with Advanced Myelodysplastic Syndromes (MDS).

Melita K Kenealy, MBBS, FRACP, FRCPA, John F Seymour, MBBS, PhD, FRACP, Cowan Linda, Alvin Milner, Pratyush Giri, Shir-Jing Ho, MBBS, FRACP, FRCPA, Warwick Benson, Andrew Nicol, MBBS, FRCPA, FRACP, PhD, Philip Campbell, MBBS, FRACP, FRCPA, Ian Prosser, MBBS, FRACP, FRCPA, PhD, Craig Underhill, MBBS, FRACP, Ilona Cunningham, Anthony K. Mills, MBBS, FRACP, FRCPA, Jeffrey Szer, MBBS, FRACP, Peter Presgrave, MBBS, FRACP, FRCPA, PhD, Robin Filshie, MBChB, FRACP, FRCPA, PhD
Journal: Blood
Blood (2009) 114 (22): 1749.
https://doi.org/10.1182/blood.V114.22.1749.1749
Published: 2009
Journal Articles

A Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma.

Jesús F. San-Miguel, MD, PhD, Orhan Sezer, MD, PhD, David Siegel, Andreas Guenther, MD, Maria-Victoria Mateos, MD, PhD, Ian Prosser, MBBS, FRACP, FRCPA, PhD, Michele Cavo, MD, Joan Blade, MD, Mario Boccadoro, MD, Bourras R. Bengoudifa, Martin Klebsattel, PhD, Priscille M. Bourquelot, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3852.
https://doi.org/10.1182/blood.V114.22.3852.3852
Published: 2009